November 17, 2006

Kansas City Life Insurance (KCLI) is benefiting from a decline in long term interest rates. When we last checked, the yield on ten year US government bonds was around 4.6%, which is down from 5.2% in June. KCLI, like most life insurers, has a large portion of its portfolio invested in fixed income securities. As interest rates fall, the market value of these securities increase and are adjusted on its balance sheet. Therefore, we were pleased, but not that surprised when we discovered that KCLI’s book value per share had increased from $53.77 to $57.43 in the third quarter.

Although investment gains are nice to have, KCLI is, after all, in the business of selling life insurance policies. From this perspective the company reported a decent third quarter. Earnings, which excludes unrealized investment gains, increased from $0.75 to $0.80 per share. Renewal premiums were essentially flat, but new premiums increased 10%. This includes a 17% increase in accident and health premiums which had been declining earlier in the year.

Also, it was good see that AM Best recently affirmed its rating on KCLI of ‘A’ (excellent). According to AM Best, the rating reflects the group's “continued strengthening in its capital and risk-based capital position, conservative balance sheet management, stable cash flow from operations and strong statutory profitability”

Although shares of KCLI are now trading around its $57 book value, the shares are clearly not expensive. KCLI still trades well below the price-to-book multiples enjoyed by many of its peers. In addition, we feel that the insurance industry in the US will eventually experience a consolidation similar to the Canadian market in the late 1990s/ early 2000s. With its strong regional presence, excellent balance sheet and strong sales force, KCLI, we believe, would make an attractive acquisition target. If it were put up for sale, it is our opinion that the company could fetch a considerable premium to its public market value.

June 22, 2007

Kansas City Life Insurance Company (KCLI) recorded a 16% increase in net income for the first quarter of 2007. The Company earned $8.3 million or $0.70 per share, an increase from $7.2 million or $0.60 per share a year earlier. Although insurance revenues declined 2% for the period, premiums from accident and health products increased 2%, including a 12% increase in new group dental sales. New sales of deposit products, including universal life, fixed deferred annuity and variable life and annuity products increased 9% versus the prior year.

One highlight of the Company's first quarter was the payment of a special dividend of $2.00 per share to shareholders in February. This payment was in addition to the company’s regular quarterly dividend of $0.27 per share. According to KCLI, “the special dividend was supported by the Company’s steady earnings and strong balance sheet.” With a market cap of $533 million, KCLI has only $14 million in long term debt. In addition, KCLI remains overcapitalized as it has more equity than required to support its current book of business. Recently, management has been using this excess liquidity to repurchase shares, pay dividends and write new insurance policies.

We believe shares of KCLI are undervalued as they currently trade at a 21% discount to their book value of $56.79 per share. As a comparison, most public life companies trade between 1 ˝ to 2 times book value. Admittedly, many of these firms earn higher returns on equity – around 12% or higher. However, KCLI’s ROE, which is currently around 6%, should eventually improve as excess capital is more efficiently deployed. If KCLI can show an increase in its ROE, Wall Street may soon discover this underfollowed company.

On a final note, while the controlling Bixby family has stated the company is not for sale, investors should not rule out a “change of heart” due to a premium offer or the need for estate planning. With its strong regional presence, experienced sales force and well capitalized business, KCLI would make an attractive acquisition candidate for a larger insurer. If the company were put up for sale we believe it would be worth considerably more than its current sock price.

February 8, 2008

The Dow Jones U.S. Financial Services Index is down 10% so far in 2008, and is off 30% since June 1st 2007. Meanwhile, shares of Kansas City Life Insurance Company are up 8.8% in 2008 and are virtually flat since June 2007. Why has KCLI held up so well while other financial stocks have faired so poorly? We believe that KCLI’s relatively good performance is due to a number of factors.

First of all, KCLI has virtually no exposure to sub-prime, Alt-A, or CDO investments. In fact, only 14% of KCLI’s investments were in mortgages and approximately 97% of these are commercial loans on warehouses and office properties. Therefore, KCLI has only small exposure to residential loans.

Second, KCLI maintains a very strong balance sheet. It has $668 million in equity and only $8.7 million in long term debt. This is considerably low for an insurance company. In addition, KCLI’s statutory capital exceeds the minimum capital deemed necessary to support its insurance business. In other words it has put aside significantly more money than required to pay future claims. Although this surplus provides a cushion of sorts, the company could eventually use it to pay additional special dividends, repurchase shares, or write new business.

Finally, the yield curve in the US has recently become more upward sloping and this should benefit KCLI.  As short term rates fall, annuity holders are less likely to surrender their policies. At the same time, new deposits will earn lower rates, and KCLI can invest the proceeds in higher yielding longer term bonds. This improved “spread” should eventually lead to improving earnings per share at KCLI. With its stock currently trading at a 22% discount to its $56.50 book value, we believe this valuation gap should eventually narrow as margins improve and excess capital is effectively redeployed.